Validation and clinical application of a volumetric absorptive microsampling method for 14 psychiatric drugs

Bioanalysis. 2020 Aug;12(16):1129-1147. doi: 10.4155/bio-2020-0136. Epub 2020 Aug 21.

Abstract

Aim: Volumetric absorptive microsampling offers a hematocrit insensitive way for microsampling. The aim of this study was to develop a method for routine healthcare for 14 antidepressants, antipsychotics and their active metabolites on a single-quadrupole HPLC-MS. A clinical validation study to determine conversion factors from capillary blood to plasma concentration was conducted afterward. Results: The method was validated according to current guidelines except for one substance. Five substances were measured in 49 patient samples and conversion factors could be derived with Passing-Bablok and Bland-Altman analysis. Conclusion: A reliable extraction and analysis method for commonly used antidepressants and antipsychotics was developed and validated. The method with the obtained conversion factors can now be used in routine healthcare.

Keywords: LC–MS; Mitra; VAMS; antidepressants; antipsychotics; clinical validation; dried blood spots; therapeutic drug monitoring; validation; volumetric absorptive microsampling.

MeSH terms

  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use*
  • Humans
  • Validation Studies as Topic

Substances

  • Antipsychotic Agents